Shared decision making with patients on contralateral prophylactic mastectomy. @ABSGBI https://t.co/QXbkdct6tf
ไม่ได้ประโยชน์จากการทำ contralateral prophylactic mastectomy ใน unilateral breast cancer https://t.co/B0brNghKr2
CPM should be discouraged for an average-risk woman with unilateral breast cancer @ASBrS @AnnSurgOncol https://t.co/Pb3Z3wr22K
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @doctorkarpoff: CPM consensus statement from ASBrS for those who missed it https://t.co/QpKRcxJCsj
CPM consensus statement from ASBrS for those who missed it https://t.co/QpKRcxJCsj
RT @DrAttai: the full statements part 1: https://t.co/4TCUGnLG6G part 2: https://t.co/y2Jp83eKwU #bcsm - open access via @AnnSurgOncol
RT @DrAttai: Tonight's #bcsm - discussion of @ASBrS 2 part CPM statement https://t.co/4TCUGnLG6G, https://t.co/y2Jp83eKwU all are welcome 9…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast… https://t.co/nQdv9RhBnA #breastcancer
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
Great articles re: contralateral prophylactic mastectomies! Thank you ASBrS! https://t.co/GmN5QC2ZvW https://t.co/xpbBi2pVpY
RT @patriciaclarkmd: ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. ht…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @jamecancerdoc: low risk patients #breastcancer removal of normal breast is not indicated. @CleClinicMD #bcsm https://t.co/9AYN14Oovp
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
ASBS position statement on contralateral mastectomy. Contralateral recurrence risk 0.5%/yr with adjuvant therapies. https://t.co/xIlKg9vEMB
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @DrJudyBoughey: Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @AS…
low risk patients #breastcancer removal of normal breast is not indicated. @CleClinicMD #bcsm https://t.co/9AYN14Oovp
Know when to consider CPM. @ASBrS recommendations. Great work @DrJudyBoughey et al https://t.co/iuHLczAtSG
Am Soc Breast Surgeons Recommends Against Routine Use Contralateral Prophylactic Mastectomy https://t.co/pmI0wixJq1
Our CPM Consensus Statements published online https://t.co/JbY7i1SX3r … (part 1) https://t.co/LLipx5DeSM … (part 2) @ASBrS @AnnSurgOncol
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons https://t.co/fSzOLiLfl4
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
RT @DrAttai: .@ASBrS CPM consensus statement via @AnnSurgOncol (open access) pt 1 https://t.co/4TCUGnLG6G, pt 2 https://t.co/y2Jp83eKwU #bc…
RT @DrAttai: .@ASBrS CPM consensus statement via @AnnSurgOncol (open access) pt 1 https://t.co/4TCUGnLG6G, pt 2 https://t.co/y2Jp83eKwU #bc…
RT @DrAttai: .@ASBrS CPM consensus statement via @AnnSurgOncol (open access) pt 1 https://t.co/4TCUGnLG6G, pt 2 https://t.co/y2Jp83eKwU #bc…
RT @ASBrS: ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQH…
ASBrS Releases Contralateral Prophylactic Mastectomy Consensus Statement https://t.co/Ynp2mP18tQ (part 1) https://t.co/tLAVVgQHkt (part 2)